In Vitro Characterization of Human, Mouse, and Zebrafish MCT8 Orthologues

In Vitro Characterization of Human, Mouse, and Zebrafish MCT8 Orthologues: Thyroid, Ahead of Print.



We use cookies to give you a better experience on liebertpub.com. By continuing to use our site, you are agreeing to the use of cookies as set in our Cookie Policy.OK



Mary Ann Leibert Logo

ABOUT US

PUBLICATIONS

AUTHORS

LIBRARIANS

OPEN ACCESS

ADVERTISING

CUSTOM



ThyroidAhead of Print

In Vitro Characterization of Human, Mouse, and Zebrafish MCT8 Orthologues

Stefan Groeneweg, Simone Kersseboom, Amanda van den Berge, Anna Dolcetta-Capuzzo, Ferdy S. van Geest, Ramona E.A. van Heerebeek, Francisco J. Arjona, Marcel E. Meima, Robin P. Peeters, W. Edward Visser, and Theo J. Visser

Published Online:7 Oct 2019https://doi.org/10.1089/thy.2019.0009

View Article

Tools

Share

Abstract

Background: Mutations in the thyroid hormone (TH) transporter monocarboxylate transporter 8 (MCT8) cause MCT8 deficiency, characterized by severe intellectual and motor disability and abnormal serum thyroid function tests. Various Mct8 knock-out mouse models as well as mct8 knock-out and knockdown zebrafish models are used as a disease model for MCT8 deficiency. Although important for model eligibility, little is known about the functional characteristics of the MCT8 orthologues in these species. Therefore, we here compared the functional characteristics of mouse (mm) MCT8 and zebrafish (dr) Mct8 to human (hs) MCT8.



Methods: We performed extensive transport studies in COS-1 and JEG-3 cells transiently transfected with hsMCT8, drMct8, and mmMCT8. Protein expression levels and subcellular localization were assessed by immunoblotting, surface biotinylation, and immunocytochemistry. Sequence alignment and structural modeling were used to interpret functional differences between the orthologues.



Results: hsMCT8, drMct8, and mmMCT8 all facilitated the uptake and efflux of 3,3′-diiodothyronine (3,3′-T2), rT3, triiodothyronine (T3), and thyroxine (T4), although the initial uptake rates of drMct8 were 1.5–4.0-fold higher than for hsMCT8 and mmMCT8. drMct8 exhibited 3–50-fold lower apparent IC50 values than hsMCT8 and mmMCT8 for all tested substrates, and substrate preference of drMct8 (3,3′-T2, T3 > T4 > rT3) differed from hsMCT8 and mmMCT8 (T3 > T4 > rT3, 3,3′-T2). Compared with hsMCT8 and mmMCT8, cis-inhibition studies showed that T3 uptake by drMct8 was inhibited at a lower concentration and by a broader spectrum of TH metabolites. Total and cell surface expression levels of drMct8 and hsMCT8 were equal and both significantly exceeded those of mmMCT8. Structural modeling located most non-conserved residues outside the substrate pore, except for H192 in hsMCT8, which is replaced by a glutamine in drMct8. However, a H192Q substituent of hsMCT8 did not alter its transporter characteristics.



Conclusion: Our studies substantiate the eligibility of mice and zebrafish models for human MCT8 deficiency. However, differences in the intrinsic transporter properties of MCT8 orthologues may exist, which should be realized when comparing MCT8 deficiency in different in vivo models. Moreover, our findings may indicate that the protein domains outside the substrate channel may play a role in substrate selection and protein stability.



Figures

References

Related

Details

View details for Thyroid cover image

Information

Copyright 2019, Mary Ann Liebert, Inc., publishers



To cite this article:

Stefan Groeneweg, Simone Kersseboom, Amanda van den Berge, Anna Dolcetta-Capuzzo, Ferdy S. van Geest, Ramona E.A. van Heerebeek, Francisco J. Arjona, Marcel E. Meima, Robin P. Peeters, W. Edward Visser, and Theo J. Visser.Thyroid.http://doi.org/10.1089/thy.2019.0009

Online Ahead of Print:October 7, 2019

Online Ahead of Editing: August 22, 2019

Keywords

monocarboxylate transporter 8MCT8orthologuesfunctional characteristicssubstrate specificityAllan-Herndon-Dudley syndromeAHDSMCT8 deficiency

Acknowledgments

The authors thank Selmar Leeuwenburgh for the technical assistance; the Optical Imaging Center (Erasmus Medical Center Rotterdam) for technical support regarding the confocal imaging studies.